🇺🇸 FDA
Pipeline program

Osilodrostat (Isturisa)

IRB00511675

Approved small_molecule active

Quick answer

Osilodrostat (Isturisa) for Mild Autonomous Cortisol Secretion (MACS) is a Approved program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Mild Autonomous Cortisol Secretion (MACS)
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials